Chemical Formula: C16H22ClN3O2

Chemical Formula C16H22ClN3O2

Found 12 metabolite its formula value is C16H22ClN3O2

Renzapride

4-Amino-N-{1-azabicyclo[3.3.1]nonan-4-yl}-5-chloro-2-methoxybenzene-1-carboximidate

C16H22ClN3O2 (323.1400462)


   

TEB_M324a

TEB_M324a

C16H22ClN3O2 (323.1400462)


CONFIDENCE Transformation product, tentative ID (Level 2b); INTERNAL_ID 2501

   

TEB_M324b *

TEB_M324b *

C16H22ClN3O2 (323.1400462)


CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2504

   

TEB_M324c

TEB_M324c

C16H22ClN3O2 (323.1400462)


CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2505

   

Renzapride

Renzapride

C16H22ClN3O2 (323.1400462)


Renzapride (BRL 24924), a substituted benzamide, is a full 5-HT4 receptor agonist with a Ki value of 115 nM. Renzapride (BRL 24924) is also a 5HT2b and 5HT3 receptor antagonist[1]. Renzapride could be used for constipation predominant irritable bowel syndrome (C-IBS) study[2].

   
   

2-chloro-N-cyclopentyl-5-(3,3-diethoxy-1-propyn-1-yl)-4-Pyrimidinamine

2-chloro-N-cyclopentyl-5-(3,3-diethoxy-1-propyn-1-yl)-4-Pyrimidinamine

C16H22ClN3O2 (323.1400462)


   

Benzamide, 4-amino-N-1-azabicyclo(3.3.1)non-4-yl-5-chloro-2-methoxy-

Benzamide, 4-amino-N-1-azabicyclo(3.3.1)non-4-yl-5-chloro-2-methoxy-

C16H22ClN3O2 (323.1400462)


   

5-(4-Chlorophenyl)-2,2-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentane-1,3-diol

5-(4-Chlorophenyl)-2,2-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentane-1,3-diol

C16H22ClN3O2 (323.1400462)


   

1-[(2r)-2-Aminobutanoyl]-N-(3-Chlorobenzyl)-L-Prolinamide

1-[(2r)-2-Aminobutanoyl]-N-(3-Chlorobenzyl)-L-Prolinamide

C16H22ClN3O2 (323.1400462)


   

Renzaprida

Renzaprida

C16H22ClN3O2 (323.1400462)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists

   

(S)-Renzapride

(S)-Renzapride

C16H22ClN3O2 (323.1400462)


(S)-Renzapride ((S)-BRL 24924) is the isomer of HY-14147 Renzapride. Renzapride is a 5-HT4 receptor agonist with a Ki value of 115 nM. Renzapride also is a 5HT2b and 5HT3 receptor antagonist. Renzapride can be used for constipation predominant irritable bowel syndrome (C-IBS) study[1][2].